PDT Partners’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-38,846
| Closed | -$1.78M | – | 811 |
|
|
2024
Q3 | $1.78M | Sell |
38,846
-9
| -0% | -$413 | 0.16% | 236 |
|
|
2024
Q2 | $1.59M | Sell |
38,855
-84,176
| -68% | -$3.44M | 0.15% | 244 |
|
|
2024
Q1 | $3.14M | Buy |
123,031
+31,431
| +34% | +$802K | 0.3% | 105 |
|
|
2023
Q4 | $829K | Buy |
+91,600
| New | +$829K | 0.09% | 317 |
|
|
2023
Q1 | – | Sell |
-70,032
| Closed | -$1.55M | – | 694 |
|
|
2022
Q4 | $1.55M | Buy |
+70,032
| New | +$1.55M | 0.25% | 134 |
|
|
2022
Q2 | – | Sell |
-33,198
| Closed | -$613K | – | 1128 |
|
|
2022
Q1 | $613K | Sell |
33,198
-4,016
| -11% | -$74.2K | 0.05% | 524 |
|
|
2021
Q4 | $885K | Buy |
37,214
+2,814
| +8% | +$66.9K | 0.07% | 395 |
|
|
2021
Q3 | $847K | Buy |
34,400
+6,500
| +23% | +$160K | 0.06% | 376 |
|
|
2021
Q2 | $689K | Buy |
+27,900
| New | +$689K | 0.05% | 448 |
|